tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Hester Biosciences Publishes Extract of Q3 and Nine-Month FY2025 Results

Story Highlights
  • Hester Biosciences reported consolidated unaudited results for Q3 and nine months ended December 2025.
  • The company published result extracts in Ahmedabad newspapers, reinforcing regulatory compliance and investor transparency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hester Biosciences Publishes Extract of Q3 and Nine-Month FY2025 Results

Claim 50% Off TipRanks Premium

Hester Biosciences Limited ( (IN:HESTERBIO) ) has shared an announcement.

Hester Biosciences Limited, listed on both BSE and NSE under the symbol HESTERBIO, has released an extract of its consolidated unaudited financial results for the quarter and nine-month period ended 31 December 2025, along with information on standalone financial results. The company notified the exchanges that these results have been published in the Ahmedabad editions of the Financial Express in both English and Gujarati, underscoring its compliance with SEBI disclosure norms and providing public access to key financial performance data for investors and other stakeholders.

More about Hester Biosciences Limited

Average Trading Volume: 238

Technical Sentiment Signal: Sell

Current Market Cap: 12.21B INR

For an in-depth examination of HESTERBIO stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1